Overview

Simplified Insulin Protocol Using Lantus in Elderly

Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if simplifying your diabetes treatment by decreasing number of insulin injections, with the help of a long acting insulin called glargine, can decrease the episodes of low blood glucose.
Phase:
Phase 4
Details
Lead Sponsor:
Joslin Diabetes Center
Collaborator:
Sanofi
Treatments:
Insulin
Insulin Glargine